BioSpace News Archive

Policy

Neptune Files Two Patent Applications for Innovative Cannabis Extraction Processes

Neptune Technologies & Bioressources Inc. has filed two applications with the United States Patent and Trademark Office (USPTO) for patents related to the extraction of cannabis material.

August 9, 2018
·
4 min read
Deals

Sentinel Capital Partners Sells WellSpring Pharma Services

Successfully Completes Third and Final Divestiture of WellSpring Platform

August 9, 2018
·
3 min read
Business

Cocrystal Pharma Reports 2018 Second Quarter Financial Results and Provides Corporate Update

First half of 2018 marked by management’s successful execution of corporate, clinical and regulatory strategies

August 9, 2018
·
8 min read
Drug Development

Audentes Therapeutics to Present at the 2018 Wedbush PacGrow Healthcare Conference

Audentes Therapeutics, Inc. today announced that Natalie Holles, President and Chief Operating Officer, will present at the 2018 Wedbush PacGrow Healthcare Conference in New York.

August 9, 2018
·
1 min read
Ironshore Pharmaceuticals Announces FDA Approval of JORNAY PMTM (Methylphenidate) Extended-Release Capsules CII for the Treatment of ADHD

JORNAY PM approved for the treatment of ADHD in patients 6 years and older

August 9, 2018
·
9 min read
Business

Juniper Pharmaceuticals Reports Second Quarter 2018 Financial and Operating Results

Signs Agreement to be Acquired by Catalent, Inc.

August 9, 2018
·
15 min read
Drug Development

BeiGene Initiates New Phase 3 Trial of Anti-PD-1 Antibody Tislelizumab Combined with Chemotherapy as First-line Treatment for Patients with Advanced Squamous Non-Small Cell Lung Cancer in China

BeiGene, Ltd. announced that the first patient was dosed in a Phase 3 clinical trial of tislelizumab, an investigational anti-PD-1 antibody, combined with chemotherapy, as a potential first-line treatment in China for patients with Stage IIIB or IV squamous non-small cell lung cancer (NSCLC).

August 9, 2018
·
6 min read
Modulus Raises 800M Japanese Yen for Its Series A Funding Round

Modulus Discovery, Inc., an early stage drug discovery company announced today that it has successfully raised a total of 800M Japanese Yen (approximately US $7.2M) for its series A round

August 9, 2018
·
3 min read
NICO Launches Investigator Initiated Study Program to Increase Scientific Data Supporting Minimally Invasive Neurosurgery

Neurosurgical medical device maker NICO Corporation has launched an Investigator Initiated Study (IIS) Program offering financial support for prospective studies or the evaluation of retrospective data related to improved patient and economic outcomes using minimally invasive neurosurgery approaches.

August 9, 2018
·
2 min read
Policy

BioPharmX Announces Patent Award, Expanding Protection for Innovations in Solid Dosage Forms

New patent protects improvements in oral drug delivery

August 9, 2018
·
3 min read